Purchase Order HHSN272201400419P
- Not listed
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The award, valued at $19,874.40, is for the procurement of 26 units of the LUCIFERASE 1000 REAGENT, Catalog # E4550, at $382.20 per unit. This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order with a completion date of March 8, 2012....
- This federal contract award is for the PROMEGA CORPORATION (doing business as Promega Corp) to provide the LUCIFERASE 1000 REAGENT to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract has a Firm Fixed Price of $90,000.00 and an ultimate completion date of November 6, 2015. The contract did not utilize a set-aside designation. As a leading life sciences company, Promega has a significant presence in the...
- This federal contract award to Promega Corporation, doing business as Promega Corp, is a Blanket Purchase Agreement (BPA) Call placed by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract is for the purchase of 26 units of the LUCIFERASE 1000 REAGENT, Catalog # E4550, at a total ceiling value of $19,874.40. The contract has a firm fixed price and does not utilize a set-aside designation. Promega, a global life...
- This federal contract award is for the procurement of 26 units of Luciferase 1000 Reagent, Cat# E4550, by the National Institute of Allergy and Infectious Diseases (NIAID) from the prime contractor Promega Corporation, doing business as Promega Corp. The $19,500.52 Firm Fixed Price BPA Call contract does not utilize a set-aside designation. Promega is a global life sciences company that develops, manufactures, and markets products and services to support biomedical research and testing...
- This federal contract award to Promega Corporation, doing business as Promega Corp, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $6,249.10 firm fixed-price purchase order is for the delivery of Promega's BRIGHT-GLO Luciferase Assay System, a specialized product used in biological research and molecular diagnostics. The award does not utilize a set-aside designation, reflecting Promega's position as...
- This federal contract award to Promega Corporation, doing business as Promega Corp, is a Blanket Purchase Agreement (BPA) call with the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $49,686 contract is for the procurement of 65 units of the Luciferase 1000 Reagent, Cat# E4550, at $382.20 per unit. This contract does not utilize a small business set-aside. Promega is a large, for-profit manufacturer of life sciences...
- This federal contract award to Promega Corporation, a global life sciences company, is for the delivery of LUCIFEREASE 1000 REAGENT, a specialized laboratory product used in biological research. The contract, valued at $48,686.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. The award does not utilize a set-aside...
- This is a $17,981.60 firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Promega Corporation, a global manufacturer of life science research products, for a 10-pack of Luciferase Assay System kits. The order was placed under a larger $11.5 million BPA Promega holds with the Defense Health Agency for DNA analysis systems, forensic reagents, and related laboratory products. This contract does not utilize any...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Promega Corporation, a large for-profit manufacturer of laboratory equipment and reagents. The contract has a ceiling value of $11,469.15 and covers the purchase of various Promega reagents, including catalog numbers MG1010 (x2), G9242, E8120, and MG1001, with shipping and handling included. The contract has a performance period through July 31, 2025 and...
- This federal contract award to Promega Corporation (Promega) was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $24,363.90 firm fixed-price purchase order is for the delivery of laboratory supplies and reagents. The contract does not have a set-aside designation. Promega, a global life sciences company headquartered in Madison, Wisconsin, provides a wide range of products and services to support biomedical...
This is a $13,289.40 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation for the purchase of luciferase reagents. The contract has an ultimate completion date of April 11, 2014 and does not utilize any set-aside designations. Promega Corporation is a global life sciences company that provides a wide range of products and services to support biomedical research and testing programs across federal agencies, including DNA analysis equipment, reagents, assays, and related laboratory supplies. In addition to this contract, Promega holds several larger federal contract vehicles with the Defense Health Agency, NIH, and FBI, providing streamlined procurement mechanisms for agencies to obtain Promega's specialized life science products and services in support of their research, healthcare, and law enforcement missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 4/8/14 |